^
    3years
    NBL-015-CSP-001: Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=410, Not yet recruiting, NovaRock Biotherapeutics, Ltd
    Clinical • New P1 trial
    |
    CLDN18 (Claudin 18)
    |
    FL-301